Age Related Macular Degeneration

AMD has two forms - wet and dry. Below is an overview of wet and dry AMD

What is the Macula?

The macula is the center part of the retina that we look straight ahead with. The eye works like a camera. The retina is like the film in the back of a camera. The center of the retina is called the macula. When you look at someone's face or read a book, you are using your macula. That is where your fine vision is. The rest of the retina is for the side or peripheral vision. You cannot see well with your peripheral vision, but you can get around and function with your peripheral vision. Macular degeneration can cause central vision loss, but never causes loss of peripheral vision (side vision).

What is Dry Macular Degeneration?

Dry AMD occurs when drusen develop in the macula (see photo). Most people with dry AMD have normal or near normal vision. Only about 10 percent develop advanced dry AMD. Advanced dry AMD occurs when the retina thins out so much that the vision declines. We call the thin spots geographic atrophy. We recommend vitamins for patients with dry AMD and fish oil. Patient with dry AMD should follow their vision and amsler grid every day and report to their physician if their is a change in vision in either eye or a change on the amsler grid. It is very important to check each eye separately.

Read more

What is Wet Macular Degeneration?

Wet AMD occurs when blood vessels start to grow in the macula. These blood vessels can also grow with scar tissue and blood (see photo). Untreated, most people with wet AMD lose their central vision. With treatment, the disease progression can usually be stopped and often reversed. Promt treatment leads to the best results, so if you have a sudden change in vision that could be a sign of wet AMD, you should see your physician urgently.

Read more

Macular Degeneration NEWS

Below are current articles from a Google News Feed on Macular Degeneration

  1. Has UVa Found a Cure for Macular Degeneration?  WMRA Public Radio
  2. Full coverage
  1. Macular degeneration biotech Kodiak Sciences sets terms for $126 million IPO  Nasdaq
  2. Full coverage
  1. Hope for new macular degeneration treatments buoys patients  The Boston Globe
  2. Age–Related Macular Degeneration Market Outlook and Opportunities in Grooming Regions 2026  Coherent Chronicle (press release) (blog)
  3. Full coverage
  1. Computers Found to Equal Humans in Diagnosing Age-Related Macular Degeneration  MD Magazine
  2. Global Gene Therapy for Age-related Macular Degeneration Market 2018 Top Manufacturers – RetroSense ...  Serie A Weekly
  3. Full coverage
  1. Age Related Macular Degeneration (AMD) Market | Global Research Insight 2018-2023 (Major Players:Bayer, F ...  TokeNexa
  2. Global Age Related Macular Degeneration Drug Market Insights, Forecast to 2025  mymarketgazette.com
  3. Age Related Macular Degeneration (AMD) | Global Market 2018 Analysis | (Bayer, F. HoffmannLa Roche, Regeneron ...  BuzEngine (press release)
  4. Full coverage
  1. Age-Related Macular Degeneration  Medical News Bulletin
  2. Full coverage
  1. Anticholinergic drug use may be associated with late AMD  Healio
  2. Full coverage
  1. Opthea to Host Wet AMD and Diabetic Macular Edema Key Opinion Leader Forum in New York City  Nasdaq
  2. Full coverage
  1. NHS wins legal fight against pharma firms over sight-loss drug  The Guardian
  2. The 10-year fight to offer a cheaper drug  BBC News
  3. NHS wins legal battle against drugs giants over saving millions with cheaper medicine  Telegraph.co.uk
  4. Full coverage
  1. Better assessments for early age-related macular degeneration  Medical Xpress
  2. Full coverage
  1. UK Health System Wins the Right to Treat AMD With Bevacizumab  The Center for Biosimilars
  2. Full coverage
  1. UVA Doctor States Possible Solution to Stop Macular Degeneration  NBC 29 News
  2. Full coverage
  1. Macular degeneration biotech Kodiak Sciences files for a $100 million IPO  Nasdaq
  2. Full coverage
  1. HL: Study: Smartphones and Sun Exposure Can Speed Up Macular Degeneration  Cape May County Herald
  2. Full coverage
  1. Age-related Macular Degeneration (AMD) -Epidemiology Market Overview, New Business Opportunities In Grooming ...  Redfield Herald (press release) (blog)
  2. Full coverage
  1. Meet the Dorchester eye specialist raising awareness of macular degeneration  Dorset Echo
  2. Full coverage
  1. CCGs win right to offer patients Avastin for wet AMD  The BMJ
  2. Novartis, Bayer consider appeal as court says Avastin can be used in AMD  pharmaphorum
  3. NHS victory over eye drug could have significant impact on UK ophthalmology sales, says analyst  The Pharma Letter
  4. Full coverage
  1. Ask The Pharmacist: 6 ways to protect your eyesight  Marco News
  2. Full coverage
  1. Brolucizumab Reports Retinal Fluid Reduction in Phase 3 Analysis  MD Magazine
  2. Full coverage
  1. MACUSTAR is co-ordinating a European clinical study on age related macular degeneration  SciTech Europa
  2. Full coverage
» Load more

What about Resources?

Dr. Pautler's Blog
American Academy of Ophthalmology
MedlinePlus
National Institutes of Health
  • ARMD
    NIH's SeniorHealth website covers the topic of Age-Related Macular Degeneration
National Eye Institute
American Foundation for the Blind - Senior Site
  • Macular Degeneration
    Basic information about AMD and low vision; includes a self-test using an Amsler Grid
Journal of the American Medical Association (JAMA)
WebMD
LightHouse International
  • Macular Degeneration
    Provides a general overview of the basics of AMD, and a simulation showing a scene as it might be viewed by a person with AMD
Prevent Blindness America